Ice Cream Recalled Due To Undeclared Peanuts

Ice Cream Recalled Due To Undeclared Peanuts

Belfonte Dairy is announcing a recall of the 1.5 quarts (1.41 L)Chocolate to Die For” Premium Ice Cream produced at its Kansas City ice cream manufacturing facility. The product may contain undeclared peanuts. People with an allergy or severe sensitivity to peanuts run the risk of a serious or life-threatening allergic reaction if they consume these products.

The affected products were sold and distributed to customers at Hy-Vee, Cash Saver, Harps, Price Mart and Heartland Stores and distributors in the following areas:

  • Kansas City, Missouri Metro Area, including Kansas City, Kansas
  • Tulsa, Oklahoma
  • Columbia, Missouri
  • Springfield, Missouri, and surrounding areas

If consumers have the Belfonte “Chocolate to Die For” Premium Ice Cream, with the codes listed in the image below, they can return it to the place of purchase for a refund.

Affected product details

1.5-Quart Belfonte Ice Cream Flavor, “Chocolate to Die For” with UPC 83057 17049 and the use by dates and plant codes detailed in the image below:

Belfonte initiated the recall after receiving a consumer complaint, where it was discovered that the Chocolate to Die For cartons of ice cream were distributed in packages that did not declare the presence of peanuts. Belfonte has not received any reports of illness associated with this product to date.

To ensure 100% containment of the product, Belfonte Dairy is recalling all 1.5-quart packages of “Chocolate to Die For Ice Cream” with the two use-by dates indicated in the image above. Other Belfonte Dairy products are not part of this recall. 

Belfonte Ice Cream & Dairy Foods Co. is working with the FDA to thoroughly investigate the matter and comply with all necessary recall procedures.

Consumers with questions may contact Belfonte seven days a week from 8 a.m. to 5 p.m. CST via email at or by calling 1-816-231-2000

Members of the media may contact Belfonte’s Media Relations seven days a week from 8 a.m. to 5 p.m. CST at 1-402-740-2254 or via email at [email protected]

Read the full report here.

As published on